Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Pharmacokinetics/Pharmacodynamics Biomarker Study in Active Ulcerative Colitis Patients

ClinicalTrials.gov ID: NCT01284062

Public ClinicalTrials.gov record NCT01284062. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 6:10 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2a, Randomized, Double-blind, Sponsor Unblinded, Placebo-controlled, Multiple Dose Study To Evaluate The Pharmacodynamics, Pharmacokinetics And Safety Of Anrukinzumab In Subjects With Active Ulcerative Colitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study represents the first investigation of anrukinzumab in patients with active ulcerative colitis (UC) and will evaluate proof of mechanism by changes in the mechanism based biomarker (YKL 40) and pharmacodynamic biomarkers (fecal calprotectin, lactoferrin and hs-CRP). It will provide further assessment of the safety, tolerability, and pharmacokinetics (PK) by administration of multiple intravenous (IV) doses of anrukinzumab.

Study identification

NCT ID
NCT01284062
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
84 participants

Conditions and interventions

Interventions

Biological · Other

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2011 (Type not available)
Primary completion
Apr 2013 (Actual)
Completion
Apr 2013 (Actual)
Last update posted
Nov 18, 2014

2011 – 2013

United States locations

U.S. sites
48
U.S. states
14
U.S. cities
22
Facility City State ZIP Site status
The Kirkland Clinic Birmingham Alabama 35233 —
UAB Hospital Birmingham Alabama 35233 —
UAB Hospital Department of Pharmacy Birmingham Alabama 35249 —
Administrative Offices Birmingham Alabama 35294 —
UAB ACIP Birmingham Alabama 35294 —
Arizona Surgical Center Phoenix Arizona 85006 —
Dedicated Phase I, Inc. Phoenix Arizona 85013 —
AGMG Endoscopy Center Anaheim California 92801 —
Anaheim Clinical Trials, LLC Anaheim California 92801 —
West Coast Radiology Center Santa Ana California 92705 —
Endoscopy Center of Connecticut, LLC Hamden Connecticut 06518 —
Gastroenterology Center of Connecticut, PC Hamden Connecticut 06518 —
Medical Research Center of Connecticut, LLC Hamden Connecticut 06518 —
International Clinical Research - US, LLC Sanford Florida 32771 —
Gastrointestinal Specialists of Georgia, PC Marietta Georgia 30060 —
GI Diagnostics Marietta Georgia 30067 —
Gastrointestinal Associates, PA Jackson Mississippi 39202 —
Gastrointestional Associates, PA Jackson Mississippi 39202 —
St. Dominic Hospital Jackson Mississippi 39216 —
Digestive Health Specialists, PA Tupelo Mississippi 38801 —
North Mississippi Medical Center Tupelo Mississippi 38801 —
Premier Medical Group of the Hudson Valley Poughkeepsie New York 12601 —
Piedmont Gastroenterology Specialists Winston-Salem North Carolina 27103 —
PMG Research of Winston-Salem Winston-Salem North Carolina 27103 —
University Hospitals Case Medical Center - Division of Gastroenterology and Liver Disease Cleveland Ohio 44106 —
Wheeler and Stuckey, Inc. Oklahoma City Oklahoma 73103 —
Oklahoma Foundation for Digestive Research Oklahoma City Oklahoma 73104 —
OU Physicians Building Oklahoma City Oklahoma 73104 —
Memphis Gastroenterology Group, PC Germantown Tennessee 38138 —
The West Clinic Memphis Tennessee 38120 —
Centennial Medical Center Physicians Park Nashville Tennessee 37203 —
Centennial Medical Center Tower Medical Imaging Nashville Tennessee 37203 —
Columbia Medical Group - The First Clinic Inc. Nashville Tennessee 37203 —
Radiology Alliance Nashville Tennessee 37203 —
Professional Quality Research, Inc. Austin Texas 78705 —
Austin Endoscopy Center Austin Texas 78757 —
Austin Gastroenterology, PA Austin Texas 78757 —
Texas Center for Drug Development, Inc. Houston Texas 77081 —
Austin Gastroenterology, PA Round Rocks Texas 78681 —
Cardiology Clinic of San Antonio San Antonio Texas 78229 —
Gastroenterology Research of San Antonio San Antonio Texas 78229 —
San Antonio Endoscopy Center San Antonio Texas 78229 —
CNS Pharmacy Murray Utah 84123 —
RGL Medical Services Salt Lake City Utah 84084 —
Alpine Medical Group Salt Lake City Utah 84102 —
Wasatch Clinical Research Salt Lake City Utah 84107 —
Wasatch Endoscopy Center Salt Lake City Utah 84124 —
University of Utah Hospital Salt Lake City Utah 84132 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 28 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01284062, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 18, 2014 · Synced Nov 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01284062 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →